GLP Peptide
From $79.99
Dual GIP/GLP-1 receptor agonist for metabolic pathway research. Lyophilized powder, ≥99% purity verified via HPLC and mass spectrometry. Certificate of Analysis included with every order. For research and laboratory use only.
GLP2-TZ is a synthetic dual-agonist peptide targeting both GIP and GLP-1 receptors. This dual-receptor agonist represents a key advancement in metabolic research, enabling investigators to study the combined effects of incretin pathway activation in controlled laboratory settings.
Each vial contains pharmaceutical-grade lyophilized GLP2-TZ powder, sealed under sterile conditions for maximum stability and shelf life. The compound is independently verified to ≥99% purity by third-party HPLC and mass spectrometry analysis.
Available in 10mg and 20mg configurations to support a range of in-vitro research protocols.
| Compound | GLP2-TZ (Tirzepatide analog) |
| Purity | ≥99% (HPLC verified) |
| Form | Lyophilized powder |
| Available Sizes | 10mg, 20mg |
| Storage | Store at -20°C. Protect from light. |
| Reconstitution | Bacteriostatic water or sterile saline |
| Molecular Target | GIP/GLP-1 dual receptor agonist |
| Testing | HPLC, Mass Spectrometry, Endotoxin |
| COA | Included with every order |
GLP2-TZ has been the subject of extensive preclinical research investigating dual-receptor agonism in metabolic pathways. Key areas of published in-vitro and animal model research include:
All research references are available upon request. This compound is sold exclusively for in-vitro and laboratory research use.
All sales are final once shipped. Refunds available only if order hasn't shipped or wrong product received — contact us within 7 days.
GLP2-TZ
$79.99
All products are for research and laboratory use only. Not for human consumption.
